Literature DB >> 15371650

Interobserver reproducibility of DNA-image-cytometry in ASCUS or higher cervical cytology.

Vu Quoc Huy Nguyen1, Hans Jürgen Grote, Natalia Pomjanski, Kristiane Knops, Alfred Böcking.   

Abstract

In the present study, the aim has been to investigate the interobserver reproducibility of DNA-image-cytometry (DNA-ICM) applied to routine Pap smears classified as Atypical Squamous Cells of Undetermined Significance (ASCUS) or higher lesions (ASCUS+). 202 Pap smears diagnosed as ASCUS or higher were included in the study. After cytological assessment, smears underwent restaining according to Feulgen. First measurements were performed as routine workup. The second measurements were blinded to the result of the first and consecutively performed. DNA-ICM met the consensus statements of the European Society of Analytical Cellular Pathology (ESACP). Interobserver agreement was assessed by calculating Kappa statistics. The diagnosis of DNA-aneuploidy in the first measurements was confirmed in all cases. Second measurement detected 12 additional cases with aneuploidy. Nine out of these cases were classified as aneuploidy by detection of 9c Exceeding Events (9cEE). In three cases stemline-aneuploidy was disclosed. The overall proportion of observed agreement was 94.1%, kappa=0.87, 95% CI=0.74-0.99. Our study shows a good interobserver reproducibility of DNA-ICM performed on cervical smears with ASCUS or higher lesions. DNA-ICM thus represents a highly reproducible diagnostic procedure.

Mesh:

Substances:

Year:  2004        PMID: 15371650      PMCID: PMC4611119          DOI: 10.1155/2004/186589

Source DB:  PubMed          Journal:  Cell Oncol        ISSN: 1570-5870            Impact factor:   6.730


  2 in total

1.  Correlation of DNA ploidy with progression of cervical cancer.

Authors:  M Singh; S Mehrotra; N Kalra; U Singh; Y Shukla
Journal:  J Cancer Epidemiol       Date:  2008-01-29

2.  Automated detection of cancer cells in effusion specimens by DNA karyometry.

Authors:  Alfred H Böcking; David Friedrich; Dietrich Meyer-Ebrecht; Chenyan Zhu; Anna Feider; Stefan Biesterfeld
Journal:  Cancer Cytopathol       Date:  2018-10-19       Impact factor: 5.284

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.